Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pacific Biosciences

Explore full profile

Biotechnology company manufacturing systems for gene sequencing and real-time biological observations

Menlo Park, United StatesFounded 2004Biotech & Life Sciences
Valuation $861M Market cap · Aug/2026
Revenue $167M Latest reported FY

At a glance

Status
Listed
Founded
2004
Headquarters
Menlo Park, United States
Listing
IPO 2010
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later14 investors entered at this stage

Employees mapped 587 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
21 countries with
team presence
🇺🇸 United States82.5%
🇬🇧 United Kingdom3%
🇩🇪 Germany2.4%
🇨🇳 China2.3%
🇸🇬 Singapore1.8%
Top 5 of 21 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States101.1%
🇪🇸 Spain1.1%
Top 2 markets shown

Patents

Estimated portfolio value
$314M

245 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Pacific Biosciences was the backer or acquirer, 2021–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Pacific Biosciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Pacific Biosciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Pacific Biosciences's portfolio, mapped.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Pacific Biosciences on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Pacific Biosciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.